The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Acceptance of a COVID-19 Vaccine in Southeast Asia: A Cross-Sectional Study in Indonesia
Open accessAbstract
Introduction: Several vaccine candidates are being clinically tested in response to the 2019 coronavirus disease (COVID-19) pandemic. This study was conducted to assess the acceptance of a 50% or 95% effective COVID-19 vaccine, when it becomes available in southeast Asia, among the general population in Indonesia. Methods: A cross-sectional online survey was conducted between March 25 and April 6, 2020. Participants were asked if they would accept a free vaccine which was 95% or 50% effective. Using a logistic regression model, we assessed the associations between sociodemographic characteristics, exposure to COVID-19 information, or perceived risk of infection and acceptance of a hypothetical COVID-19 vaccine. Results: Among 1,359 respondents, 93.3% of respondents (1,268/1,359) would like to be vaccinated for a 95% effective vaccine, but this acceptance decreased to 67.0% (911/1,359) for a vaccine with 50% effectiveness. For a 95% effective vaccine, being a healthcare worker and having higher perceived risk of COVID-19 infection were associated with higher acceptance, adjusted odds ratio (aOR): 2.01; 95%CI: 1.01, 4.00 and aOR: 2.21; 95%CI: 1.07, 4.59, respectively; compared to civil servants, being retired was associated with less acceptance (aOR: 0.15; 95%CI: 0.04, 0.63). For a 50% effective vaccine, being a healthcare worker was also associated with greater acceptance, aOR: 1.57; 95%CI: 1.12, 2.20. Conclusion: Acceptance of a COVID-19 vaccine was highly influenced by the baseline effectiveness of the vaccine. Preparing the general population to accept a vaccine with relatively low effectiveness may be difficult.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016
Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1
van Doremalen, N., Bushmaker, T., Morris, D. H., Holbrook, M. G., Gamble, A., Williamson, B. N., Tamin, A., Harcourt, J. L., Thornburg, N. J., Gerber, S. I., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2004973 · Cited by 9,951
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
Cao, B., Wang, Y., Wen, D., Liu, W., Wang, J., Fan, G., Ruan, L., Song, B., Cai, Y., Wei, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001282 · Cited by 5,187
Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy
Onder, G., Rezza, G., & Brusaferro, S. (2020) · JAMA · doi:10.1001/jama.2020.4683 · Cited by 4,171
Estimates of the severity of coronavirus disease 2019: a model-based analysis
Verity, R., Okell, L. C., Dorigatti, I., Winskill, P., Whittaker, C., Imai, N., Cuomo-Dannenburg, G., Thompson, H., Walker, P. G. T., Fu, H., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30243-7 · Cited by 3,660
Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis
Rodriguez-Morales, A. J., Cardona-Ospina, J. A., Gutiérrez-Ocampo, E., Villamizar-Peña, R., Holguin-Rivera, Y., Escalera-Antezana, J. P., Alvarado-Arnez, L. E., Bonilla-Aldana, D. K., Franco-Paredes, C., Henao-Martinez, A. F., et al. (2020) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2020.101623 · Cited by 2,542
Self-citationThe COVID-19 vaccine development landscape
Thanh Le, T., Andreadakis, Z., Kumar, A., Gómez Román, R., Tollefsen, S., Saville, M., & Mayhew, S. (2020) · Nature Reviews Drug Discovery · doi:10.1038/d41573-020-00073-5 · Cited by 1,954
Developing Covid-19 Vaccines at Pandemic Speed
Lurie, N., Saville, M., Hatchett, R., & Halton, J. (2020) · New England Journal of Medicine · doi:10.1056/nejmp2005630 · Cited by 1,557
Determinants of COVID-19 Vaccine Acceptance in Saudi Arabia: A Web-Based National Survey
Al-Mohaithef, M., & Padhi, B. K. (2020) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s276771 · Cited by 749
Vaccinations in the third world: A consideration of community demand
Nichter, M. (1995) · Social Science & Medicine · doi:10.1016/0277-9536(95)00034-5 · Cited by 223
Ma, C., Gu, J., Hou, P., Zhang, L., Bai, Y., Guo, Z., Wu, H., Zhang, B., Li, P., & Zhao, X. (2020) · medRxiv · doi:10.1101/2020.03.17.20037572 · Cited by 217
Harapan, H., Rajamoorthy, Y., Anwar, S., Bustamam, A., Radiansyah, A., Angraini, P., Fasli, R., Salwiyadi, S., Bastian, R. A., Oktiviyari, A., et al. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-018-3006-z · Cited by 200
Self-citationHarapan, H., Setiawan, A. M., Yufika, A., Anwar, S., Wahyuni, S., Asrizal, F. W., Sufri, M. R., Putra, R. P., Wijayanti, N. P., Salwiyadi, S., et al. (2020) · Pathogens and Global Health · doi:10.1080/20477724.2020.1743037 · Cited by 194
Self-citationGidengil, C. A., Parker, A. M., & Zikmund-Fisher, B. J. (2012) · American Journal of Public Health · doi:10.2105/ajph.2011.300407 · Cited by 184
Fu, C., Zheng, W., Zhu, F., Pei, S., Li, S., Zhang, L., Sun, X., Wu, Y., Liu, P., & Jit, M. (2020) · medRxiv · doi:10.1101/2020.04.09.20060103 · Cited by 161
COVID ‐19 and older people in Asia: Asian Working Group for Sarcopenia calls to action
Lim, W. S., Liang, C., Assantachai, P., Auyeung, T. W., Kang, L., Lee, W., Lim, J., Sugimoto, K., Akishita, M., Chia, S., et al. (2020) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.13939 · Cited by 137
Vasilevska, M., Ku, J., & Fisman, D. N. (2014) · Infection Control and Hospital Epidemiology · doi:10.1086/676427 · Cited by 120
Parents’ hesitancy towards vaccination in Indonesia: A cross-sectional study in Indonesia
Yufika, A., Wagner, A. L., Nawawi, Y. S., Wahyuniati, N., Anwar, S., Yusri, F., Haryanti, N., Wijayanti, N. P., Rizal, R., Fitriani, D., et al. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.01.072 · Cited by 112
Self-citationHadisoemarto, P. F., & Castro, M. C. (2013) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002427 · Cited by 93
Harapan, H., Anwar, S., Setiawan, A. M., & Sasmono, R. T. (2016) · Vaccine · doi:10.1016/j.vaccine.2016.05.026 · Cited by 91
Self-citationCovid-19 risks and response in South Asia
Bhutta, Z. A., Basnyat, B., Saha, S. K., & Laxminarayan, R. (2020) · BMJ · doi:10.1136/bmj.m1190 · Cited by 87
Rajamoorthy, Y., Radam, A., Taib, N. M., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0215125 · Cited by 83
Self-citationLee, J.-S., Mogasale, V., Lim, J. K., Carabalí, M., Sirivichayakul, C., Anh, Đ. Đ., Lee, K.-S., Thiểm, V. Đ., Limkittikul, K., Tho, L. H., et al. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003810 · Cited by 75
Harapan, H., Anwar, S., Bustamam, A., Radiansyah, A., Angraini, P., Fasli, R., Salwiyadi, S., Bastian, R. A., Oktiviyari, A., Akmal, I., et al. (2016) · Acta Tropica · doi:10.1016/j.actatropica.2016.11.035 · Cited by 71
Self-citationExploring parents’ reasons for incomplete childhood immunisation in Indonesia
Syiroj, A. T. R., Pardosi, J. F., & Heywood, A. E. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.08.081 · Cited by 71
Harapan, H., Setiawan, A. M., Yufika, A., Anwar, S., Wahyuni, S. I., Asrizal, F. W., Sufri, M. R., Putra, R. P., Wijayanti, N. P., Salwiyadi, S., et al. (2020) · Acta Tropica · doi:10.1016/j.actatropica.2020.105450 · Cited by 71
Self-citationCommunity awareness, use and preference for pandemic influenza vaccines in Pune, India
Sundaram, N., Purohit, V. S., Schaetti, C., Kudale, A., Joseph, S., & Weiss, M. G. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1062956 · Cited by 66
Yeo, H. Y., & Shafie, A. A. (2018) · Cost Effectiveness and Resource Allocation · doi:10.1186/s12962-018-0163-2 · Cited by 61
A conjoint analysis of stated vaccine preferences in Shanghai, China
Sun, X., Wagner, A. L., Ji, J., Huang, Z., Zikmund‐Fisher, B. J., Boulton, M. L., Ren, J., & Prosser, L. A. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.11.062 · Cited by 55
Self-citationWagner, A. L., Boulton, M. L., Sun, X., Mukherjee, B., Huang, Z., Harmsen, I. A., Ren, J., & Zikmund‐Fisher, B. J. (2017) · BMC Pediatrics · doi:10.1186/s12887-017-0900-2 · Cited by 54
Self-citationHarapan, H., Mudatsir, M., Yufika, A., Nawawi, Y. S., Wahyuniati, N., Anwar, S., Yusri, F., Haryanti, N., Wijayanti, N. P., Rizal, R., et al. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.01.062 · Cited by 50
Self-citationAcceptability of seasonal influenza vaccines among health care workers in Vietnam in 2017
Nguyen, T. T. M., Lafond, K. E., Nguyen, T. X., Tran, P. D., Nguyen, H. M., Ha, V. T. C., Do, T. T., Ha, N. T., Seward, J. F., & McFarland, J. W. (2020) · Vaccine · doi:10.1016/j.vaccine.2019.12.047 · Cited by 46
Rajamoorthy, Y., Radam, A., Taib, N. M., Rahim, K. A., Wagner, A. L., Mudatsir, M., Munusamy, S., & Harapan, H. (2018) · PLoS ONE · doi:10.1371/journal.pone.0208402 · Cited by 37
Self-citationWillingness-to-pay for a hypothetical Ebola vaccine in Indonesia: A cross-sectional study in Aceh
Mudatsir, M., Anwar, S., Fajar, J. K., Yufika, A., Ferdian, M. N., Salwiyadi, S., Imanda, A. S., Azhars, R., Ilham, D., Timur, A. U., et al. (2019) · F1000Research · doi:10.12688/f1000research.20144.1 · Cited by 31
Self-citationHarapan, H., Setiawan, A. M., Yufika, A., Anwar, S., Wahyuni, S. I., Asrizal, F. W., Sufri, M. R., Putra, R. P., Wijayanti, N. P., Salwiyadi, S., et al. (2020) · Clinical Epidemiology and Global Health · doi:10.1016/j.cegh.2020.04.024 · Cited by 31
Self-citationHarapan, H., Rajamoorthy, Y., Utomo, P. S., Anwar, S., Setiawan, A. M., Aletta, A., Bambang, A., Ramadana, M. R., Ikram, I., Wahyuniati, N., et al. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-4297-4 · Cited by 25
Self-citationVo, T. Q., Tran, Q. V., & Vo, N. X. (2018) · Patient Preference and Adherence · doi:10.2147/ppa.s188581 · Cited by 17
Public acceptance of a hypothetical Ebola virus vaccine in Aceh, Indonesia: A hospital-based survey
Harapan, H., Anwar, S., Ferdian, M. N., Salwiyadi, S., Imanda, A. S., Azhars, R., Fika, D. F., Ilham, D., Timur, A. U., Sahputri, J., et al. (2017) · Asian Pacific Journal of Tropical Disease · doi:10.12980/apjtd.7.2017d6-386 · Cited by 7
Self-citation
Cited by
COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates
Sallam, M. (2021) · Vaccines · doi:10.3390/vaccines9020160 · Cited by 2,128
Confidence and Receptivity for COVID-19 Vaccines: A Rapid Systematic Review
Lin, C., Tu, P., & Beitsch, L. M. (2020) · Vaccines · doi:10.3390/vaccines9010016 · Cited by 839
Factors Associated with COVID-19 Vaccine Hesitancy
Soares, P., Rocha, J. V., Moniz, M., Gama, A., Laires, P. A., Pedro, A. R., Dias, S., Leite, A., & Nunes, C. (2021) · Vaccines · doi:10.3390/vaccines9030300 · Cited by 708
Sallam, M., Dababseh, D., Eid, H., Al-Mahzoum, K., Al-Haidar, A., Taim, D., Yaseen, A., Ababneh, N. A., Bakri, F. G., & Mahafzah, A. (2021) · Vaccines · doi:10.3390/vaccines9010042 · Cited by 675
The Nature and Extent of COVID-19 Vaccination Hesitancy in Healthcare Workers
Biswas, N., Mustapha, T., Khubchandani, J., & Price, J. H. (2021) · Journal of Community Health · doi:10.1007/s10900-021-00984-3 · Cited by 598
Metadata
- Authors
- Harapan, H., Wagner, A. L., Yufika, A., Winardi, W., Anwar, S., Gan, A. K., Setiawan, A. M., Rajamoorthy, Y., Sofyan, H., & Mudatsir, M.
- Venue
- Frontiers in Public Health
- Publisher
- Frontiers Media SA
- Published
- 2020-07-14
- Volume
- 8
- Pages
- 381-381
- ISSN
- 2296-2565 (ISSN-L)
- OpenAlex
- W3042766617
- Cited by
- 689
- References
- 40
- FWCI
- 83.21
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.